SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
SciClone Pharmaceuticals, Inc. and Sigma-Tau Finanziaria S.p.A. Announce Final Data From Clinical Trial of ZADAXIN as H1N1 Vaccine Enhancer